Home / Brands / Lowlite Investments, Inc.
Lowlite Investments, Inc. Recalls
105 recalls on record · July 17, 2013 to July 17, 2013 · Drugs
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls PEN-DEX-CHLOR Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Papaverine 40 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Oxytocin 20 units/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Neomycin / Polymyxin / Dexamethasone Ophthalmic Drops, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Naproxen 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Miconazole 3% Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls MICC (Methionine, Inositol, Choline, Cyanocobalamin, Chromium) Inj and MICC 25/50/330 Inj, compounded by Olympia Pharmac
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Metoclopramide 5 mg/ml Injection,compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Methylprednisolone Acetate 80 mg/ml Injection, compounded by Olympia, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Methylcobalamin 25 mg/ml Inj and 5000 mcg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Methylcobalamin 1 mg/ml / Folic Acid 2.5 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Methylcobalamin P 10/ml Creatine 40 mg/ml / Arginine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Metabolase Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Metabolase Forte Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Meloxicam 5 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Medroxyprogesterone 150 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Medetomidine 2 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Lisinopril 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Lipotoxin Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls L-ArGiNINE 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Ketoprofen Solution 10% Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Ketamine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls ITPP 50 mg/ml DMG 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Iodine 20 mg Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Idoxuridine 0.1% Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Hippiron 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls HCG 125iu/0.25ml (550iu/ml), 3500iu and 10,000iu, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls HACC 270.1 Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Guanabenz 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
July 17, 2013DrugsFDA
Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Guanabenz 8 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes